Atai Life Sciences N.V. (FRA:9VC)
Germany · Delayed Price · Currency is EUR 3.781
-0.040 (-1.05%)
Last updated: Sep 9, 2025, 8:03 AM CET
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €894.36 million as of September 10, 2025. Its market cap has increased by 358.93% in one year.
Market Cap
894.36M
Enterprise Value
822.64M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.78
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 894.36M, a decrease of -64.27%. That is a compound annual growth rate of -21.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 894.36M | 314.89% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
| Jun 18, 2021 | 2.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 268.21B |
| Siemens Aktiengesellschaft | 177.41B |
| Deutsche Telekom AG | 148.75B |
| Allianz SE | 134.60B |
| Rheinmetall AG | 81.51B |
| Siemens Energy AG | 71.89B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.57B |
| Deutsche Bank Aktiengesellschaft | 58.53B |